1. Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model

   • Stephen T. Keir
   • Henry S. Friedman
   • Lloyd A. Gray

   Laboratory Investigation 20 October 2012 Pages: 97 - 102

   

2. Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy

   • Jacky T. Yeung
   • Ronald L. Hamilton
   • Ian F. Pollack

   Laboratory Investigation 21 November 2012 Pages: 103 - 111

   

3. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells

   • Susan L. Whiteway
   • Peter S. Harris
   • Rajeev Vibhakar

   Laboratory Investigation 09 November 2012 Pages: 113 - 121

   

4. Galectin-3 in preneoplastic lesions of glioma

   • Nguyen Huy Binh
   • Kunio Satoh
   • Akira Hara

   Laboratory Investigation 23 November 2012 Pages: 123 - 132

   

5. Examination of blood–brain barrier (BBB) integrity in a mouse brain tumor model

   • Ngoc H. On
   • Ryan Mitchell
   • Donald W. Miller

   Laboratory Investigation 27 November 2012 Pages: 133 - 143

   

6. Functional FEN1 genetic variants and haplotypes are associated with glioma risk

   • Yi-Dong Chen
   • Xiaojiao Zhang
   • Ming Yang

   Laboratory Investigation 27 November 2012 Pages: 145 - 151

7. Real-time multi-modality imaging of glioblastoma tumor resection and recurrence

   • Shawn Hingtgen
   • Jose-Luiz Figueiredo
   • Khalid Shah

   Laboratory Investigation 16 December 2012 Pages: 153 - 161

   

8. Frequency of brain metastases from prostate cancer: an 18-year single-institution experience

   • Orazio Caffo
   • Antonello Veccia
   • Enzo Galligioni

   Clinical Study 25 October 2012 Pages: 163 - 167

9. Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma

   • Lucas Moreno
   • Sergey Popov
   • Stergios Zacharoulis

   Clinical Study 08 November 2012 Pages: 169 - 176

   

10. Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy

    • Paolo Farace
    • Dante Amelio
    • Alberto Beltramello

    Clinical Study 22 December 2012 Pages: 177 - 185

    

11. Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas

    • Giuseppe Minniti
    • Claudia Scaringi
    • Riccardo Maurizi Enrici

    Clinical Study 06 November 2012 Pages: 187 - 194

    

12. Restricted access to the environment and quality of life in adult survivors of childhood brain tumors

    • Tara M. Brinkman
    • Zhenghong Li
    • Kirsten K. Ness

    Clinical Study 11 November 2012 Pages: 195 - 203

    

13. Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme

    • Aida Muhic
    • Hans Skovgaard Poulsen
    • Ulrik Lassen

    Clinical Study 27 November 2012 Pages: 205 - 212

    

14. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade

    • Karoline Skogen
    • Balaji Ganeshan
    • Ken Miles

    Clinical Study 06 December 2012 Pages: 213 - 219